Thomas Christély

Thomas Christély currently works at MetrioPharm AG, as Chief Executive Officer from 2021 and Atugen AG, as Chief Executive Officer from 2001.
Mr. Christély also formerly worked at Silence Therapeutics Plc, as Chief Executive Officer from 2011 to 2012, MYR GmbH, as Managing Director & Chief Financial Officer, Arthur Andersen LLP, as Principal, Nuvo Research AG, as Chief Financial Officer & Senior Vice President in 2000, and Löschen & Partner GmbH, as Managing Partner in 1995.
Mr. Christély received his undergraduate degree and graduate degree from the University of Hamburg.